3 recruiting, 1 active not recruiting, 1 completed. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Recruiting 3, Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Germ Cell Tumor: new trials by email Literature Review of Germ Cell Tumor trials Research Report on Germ Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors Thromboprophylaxis - Germ Cell Tumor | Phase 3 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 387 | 2023-10-17 | 2025-06-15 |
| Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children sirolimus combined with chemotherapy in the treatment of recurrent/refractory yolk sac tumor in children - Germ Cell Tumor, Yolk Sac Tumor | Phase 2 / Phase 3 | Completed | Shandong First Medical University | 32 | 2020-06-01 | 2025-09-19 |
| Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Best Practice, Biopsy Procedure, Biospecimen Collection - Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma | Phase 3 | Recruiting | Children's Oncology Group | 1780 | 2017-05-25 | 2026-08-25 |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors paclitaxel, ifosfamide, cisplatin - Germ Cell Tumor, Teratoma | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 420 | 2015-08-06 | 2026-06-16 |
| Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours Bleomycin (active name: Bleomycin Sulfate), Etoposide, Cisplatin - Germ Cell Tumor | Phase 3 | Recruiting | University of Sydney | 500 | 2014-02-01 | 2026-09-01 |
Neoplasms, Germ Cell and Embryonal (5) · Endodermal Sinus Tumor (3) · Teratoma (2) · Carcinoma, Embryonal (1) · Choriocarcinoma (1) · Germinoma (1) · Nonseminomatous germ cell tumor (1) · Seminoma (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Mesonephroma (3) · Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Neoplasms, Glandular and Epithelial (1) · Pregnancy Complications (1) · Pregnancy Complications, Neoplastic (1) · Trophoblastic Neoplasms (1) · Urogenital Diseases (1)
Cisplatin (3) · Etoposide (3) · Bleomycin (2) · Carboplatin (2) · etoposide phosphate (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Biopsy (1) · Drug Therapy (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Ifosfamide (1) · Injections (1) · Magnetic Resonance Spectroscopy (1) · Paclitaxel (1) · Platinum (1)
Alliance for Clinical Trials in Oncology (1) · Children's Oncology Group (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Shandong First Medical University (1) · University of Sydney (1)
Australia (3) · United Kingdom (3) · United States (3) · France (2) · New Zealand (2) · Belgium (1) · Canada (1) · China (1) · Denmark (1) · Germany (1) · India (1) · Ireland (1) · Italy (1) · Japan (1) · Netherlands (1)
A. L Frazier (1) · Darren Feldman, MD (1) · Jingfu Wang, MD (1) · Peter Grimison (1)
PMID 30157803, PMID 30563754, PMID 37783480, PMID 39028926
U10CA180821 (1), U10CA180886 (1)